Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (3648)	11/22/2002 10:53:47 PM
From: fred hayes	Read Replies (1) \| Respond to of 10345

Yup, missed it for sure. Thanks for pointing it out -- hope they hurry up with that AD medicine. Now, for Elan Diagnostics, I would bet we're pretty close by taking the 4x revenues paid for Athena and applying it to the $21 million ED rev, or say $80 mil. ($122 mil sales price / .8) / ($36.3 rev) x ED's $21 mil rev. This assumes that ED is owned 100 percent by Elan (no minority shareholders, which I assume were baggage from the Athena acquisition). fred